WST vs. XRAY
Compare and contrast key facts about West Pharmaceutical Services, Inc. (WST) and DENTSPLY SIRONA Inc. (XRAY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: WST or XRAY.
Correlation
The correlation between WST and XRAY is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
WST vs. XRAY - Performance Comparison
Loading data...
Key characteristics
WST:
-0.71
XRAY:
-0.84
WST:
-0.65
XRAY:
-1.00
WST:
0.87
XRAY:
0.84
WST:
-0.64
XRAY:
-0.49
WST:
-1.71
XRAY:
-1.35
WST:
22.30%
XRAY:
29.14%
WST:
55.02%
XRAY:
47.16%
WST:
-59.29%
XRAY:
-80.50%
WST:
-53.51%
XRAY:
-74.17%
Fundamentals
WST:
$15.56B
XRAY:
$3.33B
WST:
$6.37
XRAY:
-$4.47
WST:
3.64
XRAY:
0.94
WST:
5.37
XRAY:
0.89
WST:
5.80
XRAY:
1.66
WST:
$2.90B
XRAY:
$3.72B
WST:
$1.00B
XRAY:
$1.92B
WST:
$729.50M
XRAY:
-$576.00M
Returns By Period
In the year-to-date period, WST achieves a -33.58% return, which is significantly lower than XRAY's -11.48% return. Over the past 10 years, WST has outperformed XRAY with an annualized return of 15.18%, while XRAY has yielded a comparatively lower -9.74% annualized return.
WST
-33.58%
7.69%
-29.18%
-38.74%
-10.04%
0.91%
15.18%
XRAY
-11.48%
29.62%
-8.22%
-39.34%
-22.29%
-15.46%
-9.74%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
WST vs. XRAY — Risk-Adjusted Performance Rank
WST
XRAY
WST vs. XRAY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for West Pharmaceutical Services, Inc. (WST) and DENTSPLY SIRONA Inc. (XRAY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
WST vs. XRAY - Dividend Comparison
WST's dividend yield for the trailing twelve months is around 0.38%, less than XRAY's 3.85% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
WST West Pharmaceutical Services, Inc. | 0.38% | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% | 0.77% |
XRAY DENTSPLY SIRONA Inc. | 3.85% | 3.37% | 1.57% | 1.57% | 0.77% | 0.76% | 0.66% | 0.95% | 0.53% | 0.54% | 0.48% | 0.50% |
Drawdowns
WST vs. XRAY - Drawdown Comparison
The maximum WST drawdown since its inception was -59.29%, smaller than the maximum XRAY drawdown of -80.50%. Use the drawdown chart below to compare losses from any high point for WST and XRAY. For additional features, visit the drawdowns tool.
Loading data...
Volatility
WST vs. XRAY - Volatility Comparison
The current volatility for West Pharmaceutical Services, Inc. (WST) is 10.56%, while DENTSPLY SIRONA Inc. (XRAY) has a volatility of 16.91%. This indicates that WST experiences smaller price fluctuations and is considered to be less risky than XRAY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
WST vs. XRAY - Financials Comparison
This section allows you to compare key financial metrics between West Pharmaceutical Services, Inc. and DENTSPLY SIRONA Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
WST vs. XRAY - Profitability Comparison
WST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported a gross profit of 231.90M and revenue of 698.00M. Therefore, the gross margin over that period was 33.2%.
XRAY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, DENTSPLY SIRONA Inc. reported a gross profit of 466.00M and revenue of 879.00M. Therefore, the gross margin over that period was 53.0%.
WST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported an operating income of 107.00M and revenue of 698.00M, resulting in an operating margin of 15.3%.
XRAY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, DENTSPLY SIRONA Inc. reported an operating income of 63.00M and revenue of 879.00M, resulting in an operating margin of 7.2%.
WST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, West Pharmaceutical Services, Inc. reported a net income of 89.80M and revenue of 698.00M, resulting in a net margin of 12.9%.
XRAY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, DENTSPLY SIRONA Inc. reported a net income of 20.00M and revenue of 879.00M, resulting in a net margin of 2.3%.